MiMedx AMNIOFIX in Spine Surgery: Laminectomy, Fusion & Microdiscectomy Applications

MiMedx AMNIOFIX in spine surgery for laminectomy fusion and microdiscectomy applications

Spine surgery often involves more than achieving decompression, stabilization, or fusion. Surgeons also have to think about what happens within the surgical field after the procedure is complete — including healing, scar formation, tissue-plane management, and the possibility that a patient may need revision surgery years later.

MiMedx AMNIOFIX in Spine Surgery: Laminectomy, Fusion & Microdiscectomy ApplicationsAMNIOFIX® is a dehydrated human amnion/chorion membrane (DHACM) placental tissue allograft from MiMedx used as a protective barrier in surgical settings.

MiMedx currently lists several spine procedures in which AMNIOFIX has been used, including laminectomy, fusion, revision surgery, microdiscectomy, endoscopic spine procedures, and acute spine wound incisions.

AMNIOFIX does not replace spine hardware, bone graft, cages, screws, rods, or other structural technologies. Its role is different: it is used as a biologic protective barrier within the surgical field.

Where AMNIOFIX Fits in Spine Surgery:

Infographic showing where MiMedx AMNIOFIX fits in spine surgery including laminectomy fusion and microdiscectomy

AMNIOFIX in LaminectomyLaminectomy is a decompression procedure in which part of the lamina is removed to create more space around the spinal canal and neural structures.

MiMedx includes laminectomy among the spine applications in which AMNIOFIX has been used as a protective barrier within the exposed surgical tissue plane.AMNIOFIX in Spinal FusionSpinal fusion may involve pedicle screws, rods, cages, bone graft, and other fixation technologies.

AMNIOFIX does not replace those products. It may be used as a complementary biologic barrier within the same procedure.

MiMedx provides a case example in which AMNIOFIX was positioned over exposed dura during a lumbar fusion and decompression procedure.AMNIOFIX in Microdiscectomy.

Microdiscectomy is a targeted decompression procedure used to remove disc material compressing a nerve root.MiMedx also lists microdiscectomy among the procedures in which AMNIOFIX has been used as a protective barrier.

The goal is not to change the decompression itself, but to provide a site-specific placental tissue barrier within the surgical environment.Why Tissue-Plane Management MattersScar tissue, fibrosis, and adhesions can make future spine surgery more challenging.

This is especially relevant in revision cases, where surgeons may need to return to a previously operated level.

A protective barrier may be useful when the surgeon wants to help maintain a cleaner or more defined tissue plane during healing.

What AMNIOFIX Is — and What It Is Not

AMNIOFIX is:A human placental tissue allograftDehydrated human amnion/chorion membraneUsed as a protective barrierPart of the broader surgical biologics category.

AMNIOFIX is not:

1. A bone graft
2. A cage
3. A fixation system
4. A pedicle screw construct
5. A dural substitute

That makes AMNIOFIX a complementary technology rather than a replacement for the structural and orthobiologic products already used in spine surgery.

Why Spine Surgery Is an Important Biologics Category

1. Spine surgery already combines mechanical and biologic technologies.
2. Hardware provides stability.
3. Bone graft materials support fusion biology.
4. Placental tissue allografts such as AMNIOFIX address a different part of the surgical environment.

That combination is one reason spine surgery is becoming an important area for surgical biologics.

About 6|Sixty Biologics

6|Sixty Biologics is an independent surgical biologics distributor focused on helping surgeons and hospitals understand and access advanced biologic technologies.

6|Sixty works with MiMedx surgical biologics, including AMNIOFIX, across multiple surgical specialties including spine and neurosurgery.

Important Information

This article is for educational purposes only and is not medical advice. Product selection and use should be based on current manufacturer labeling, Instructions for Use, clinical evidence, and individual patient circumstances.

6|Sixty Biologics is an independent distributor and is not MiMedx. AMNIOFIX®, PURION®, and MiMedx are trademarks or trade names of MiMedx Group, Inc.